Development of a dyadic sleep intervention for Alzheimer's disease patients and their caregivers.
Yeonsu Song, Susan M McCurry, Diane Lee and 7 others
PMID 31656109WHAT IT FOUND
A five-session sleep program for Alzheimer's patients and their caregivers showed promising self-reported improvements in sleep and daily habits.
It was not designed to prove efficacy, but it successfully refined materials for a future trial.
Key findings
01After the intervention, most patients and caregivers reported fewer nights taking over 30 minutes to fall asleep and reduced nighttime wakefulness.
02Caregivers and patients increased their daily walking and light exposure minutes, which were core components of the tailored sleep plan.
03The study was a Stage 1 pilot designed to refine intervention materials through feedback, not to test treatment efficacy.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only five dyads participated, which is too small to determine if the intervention works generally. The study was not designed to test efficacy, so improvements could be due to other factors like attention or placebo effects. No control group was used, so it is impossible to know what would have happened without the intervention. Sleep outcomes were based on simple diaries completed by caregivers, which may be less accurate than standard sleep measures or actigraphy. Educators had different backgrounds and experience levels, which may have influenced how the intervention was delivered.
Declared interests
The authors declared no conflicts of interest. The study was supported by the National Institute of Aging and the Department of Veterans Affairs.
The easy way to misread this
Do not view the reported sleep improvements as proof that this specific program works. The study was a small pilot with no control group, designed only to refine materials for a future trial, and some participants showed no change.